The Akt/PKB pathway: molecular target for cancer drug discovery

Area of Science:

• Oncology
• Molecular Biology
• Pharmacology

Background:

• The Akt/PKB pathway is a critical signaling node for oncogenic signals from both extracellular and intracellular sources.
• Aberrations in the Akt pathway are implicated in various human malignancies, contributing to tumor development and therapeutic resistance.
• Constitutively active Akt promotes cellular transformation, tumor formation, and chemoresistance.

Purpose of the Study:

• To review the translational efforts in developing therapeutic strategies targeting the Akt pathway for cancer treatment.
• To highlight the role of Akt signaling in regulating key tumor-associated processes.
• To discuss the potential of Akt pathway inhibitors for selective tumor cell apoptosis and growth inhibition.

Main Methods:

• Review of scientific literature focusing on Akt pathway inhibitors.
• Analysis of therapeutic strategies involving combinatorial chemistry, high-throughput screening, and medicinal chemistry.
• Examination of the downstream targets and cellular processes regulated by Akt signaling.

Main Results:

• Identification of numerous Akt pathway inhibitors through various screening and chemistry approaches.
• Demonstration that Akt signaling regulates crucial cancer cell processes including growth, survival, migration, and angiogenesis.
• Evidence that blocking Akt signaling leads to apoptosis and growth inhibition in Akt-dependent tumors.

Conclusions:

• The Akt/PKB pathway is a promising molecular target for cancer therapy.
• Targeting the Akt pathway holds potential for selective killing of tumor cells that rely on this signaling cascade for survival and growth.
• Ongoing translational research is focused on developing effective Akt pathway inhibitors for clinical application.